Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.
Imre NothVincent CottinNazia ChaudhuriTamera J CorteKerri A JohannsonMarlies WijsenbeekStéphane JouneauAndreas MichaelManuel QuaresmaKlaus B RohrAnne -Marie RussellSusanne StowasserToby M Mahernull nullPublished in: The European respiratory journal (2021)
Home spirometry was a feasible and valid measure of lung function in patients with IPF and preserved FVC, but estimates of the rate of FVC decline obtained using home spirometry were poorly correlated with those based on clinic spirometry.